Perimenopause Weight Gain Supplements, Compared (2026)
Paid link disclosure: we may earn a commission, at no extra cost to you. How we choose recommendations.
No supplement is established as a treatment for perimenopausal weight gain. The two with the most human trial data behind the underlying metabolism are berberine, where meta-analyses of randomised trials report improved glucose and insulin-resistance measures, and magnesium, where a 2016 meta-analysis of randomised trials reports an improved insulin-resistance index. Both are adjuncts. Protein, resistance training and sleep remain the levers with the strongest evidence.
If your middle feels different in your 40s, the measurement data agrees with you. In the SWAN longitudinal cohort (JCI Insight, 2019), which followed 1,246 women through the menopause transition, the rate of fat gain roughly doubled across the transition, from about 1.0% a year to 1.7% a year, while lean mass declined about 0.2% a year. Notably, the same study found overall weight and BMI did not climb faster than before, so what changes most is the composition and location of what you are carrying rather than the number on the scale. Supplements do not undo that. What a small number of well-studied ones have human trial data for is one upstream lever: how the body handles glucose and insulin. Below is what those trials found, what they failed to find, and two categories our desk would skip.
Reviewed July 2026 against published human trials only, and we report the null findings as well as the positive ones. In the 2020 dose-response meta-analysis of 10 randomised berberine trials (Complementary Therapies in Clinical Practice), waist circumference fell by about 2.75 cm and BMI by 0.29 kg/m², while body weight did not change significantly. Nothing here is a weight-loss drug, a treatment for any condition, or a substitute for a medical workup.
Our top picks at a glance
| # | Supplement | Rating | Price | |
|---|---|---|---|---|
| #1 |
Berberine
Best Overall for the Glucose Driver
|
★★★★★ 4.4/5 | From $20 | Check price → |
| #2 |
Magnesium glycinate
Best Supporting Player
|
★★★★★ 4.2/5 | From $18 | Check price → |
| #3 |
Stimulant fat-burners
What We Would Skip
|
★★★★★ 1.7/5 | $20–$60 | See review ↓ |
| #4 |
“Menopause belly” detox teas
What We Would Skip
|
★★★★★ 1.5/5 | $15–$40 | See review ↓ |
Berberine
The supplement in this category with the largest body of randomised human trial data on glucose and insulin measures.
Paid link · affiliate disclosure
Berberine
The supplement in this category with the largest body of randomised human trial data on glucose and insulin measures.
Berberine has the most human trial data of anything in this category, though almost all of it sits outside perimenopause. A 2021 systematic review and meta-analysis of 46 randomised controlled trials in 4,158 participants (Oxidative Medicine and Cellular Longevity) reported lower fasting blood glucose, HbA1c and insulin-resistance scores versus control. Read that population carefully: those participants had type 2 diabetes, not perimenopause, so this is evidence about a shared metabolic pathway rather than evidence about perimenopausal weight. On body size specifically, the 2020 dose-response meta-analysis of 10 randomised trials (Complementary Therapies in Clinical Practice) found waist circumference down about 2.75 cm and BMI down 0.29 kg/m², with no statistically significant change in body weight. It supports glucose metabolism. It does not treat, cure or reverse perimenopausal weight gain, and no trial has tested it for that purpose. Take it with meals and give it the 12-week windows the trials used. Talk to your doctor before starting, particularly if you take metformin or any other blood-sugar medication.
What we like
- Largest randomised-trial evidence base of any option here for glucose and insulin-resistance measures
- Acts on the glucose pathway, which is one documented part of the midlife metabolic picture
- Inexpensive, single ingredient, and easy to evaluate against a specific blood marker
Tradeoffs
- The trials were run in people with type 2 diabetes, not in perimenopausal women
- Meta-analysis found no significant change in body weight; the measured change was in waist and BMI
- Can interact with blood-sugar medication, so it needs a doctor conversation first
- Trials ran 12 weeks or longer, and mild GI upset is a commonly reported side effect
Magnesium glycinate
One measured effect on an insulin-resistance score, a genuinely common dietary shortfall, and weaker sleep evidence than the marketing suggests.
Magnesium is the honest supporting player, and the honest version is narrower than most roundups admit. A 2016 systematic review and meta-analysis of randomised controlled trials (Pharmacological Research) found magnesium supplementation improved the HOMA-IR insulin-resistance index, but found no significant effect on fasting glucose, insulin or HbA1c. So the measured benefit is one score, not blood sugar across the board. The shortfall it addresses is real: in the NHANES 2013-2016 national nutrition survey summarised by the NIH Office of Dietary Supplements, about 48% of Americans take in less magnesium from food and drink than the Estimated Average Requirement. On sleep, be sceptical of the usual claim. A 2021 systematic review and meta-analysis of three randomised trials in 151 older adults (BMC Complementary Medicine and Therapies) found the improvement in sleep time was modest and not statistically significant, and the reviewers rated the underlying trials small and low quality. Sleep itself does matter for appetite: a 2017 meta-analysis of human intervention studies (European Journal of Clinical Nutrition) found partial sleep deprivation raised next-day energy intake by about 385 calories with no change in energy expenditure. That is a reason to protect sleep. It is not evidence that magnesium delivers it. The glycinate form is well tolerated in the evening. It supports these systems; it does not burn fat and it treats nothing.
What we like
- Improved an insulin-resistance index in a meta-analysis of randomised trials
- Addresses a documented dietary shortfall affecting roughly half of US adults
- Glycinate form is gentle and generally well tolerated in the evening
Tradeoffs
- Same meta-analysis found no significant effect on fasting glucose, insulin or HbA1c
- Sleep benefit is weakly supported: the pooled trial result was not statistically significant
- No trial has tested it for perimenopausal weight, and it is not a fat-loss supplement
- Start low, because higher intakes can loosen stools
Stimulant fat-burners
Caffeine and thermogenic blends in a capsule, sold against a category where the pooled trial evidence is thin.
Marketed as fat-burners, these are functionally caffeine plus stimulant blends carrying a thermogenic claim. The category-level evidence is weak: a 2021 systematic review in Obesity examined 315 randomised controlled trials of dietary supplements and alternative therapies for weight loss and found only a small minority of well-designed trials showing a meaningful effect on weight. Two specific effects are better documented than the fat-burning is. In a 2005 double-blind crossover trial in 96 adults (Psychosomatic Medicine), caffeine raised cortisol across the day, and daily intake reduced but did not eliminate that response in habitual consumers. And a 2017 systematic review of epidemiological studies and randomised trials (Sleep Medicine Reviews) found caffeine lengthens the time it takes to fall asleep and reduces total sleep time and sleep efficiency. Sleep and stress are already under pressure in perimenopause, which is why our desk skips this category rather than recommending it. To be clear about what is and is not shown: raising cortisol and disrupting sleep are measured effects, whereas the claim that a burner therefore adds abdominal fat is an inference no trial here tested.
What we like
- Cheap
- Short-term alertness if you are not already a regular caffeine consumer
Tradeoffs
- Pooled evidence across 315 randomised trials found little support for supplement-driven weight loss
- Caffeine raised cortisol across the day in a double-blind crossover trial, including in habitual consumers
- Caffeine measurably delays sleep onset and shortens total sleep time
- Proprietary blends often do not disclose individual stimulant amounts
“Menopause belly” detox teas
Diuretics and laxatives dressed up as a hormonal fix. The scale moves for a day; the fat does not.
Teas sold for “menopause belly” are typically built on senna, a stimulant laxative, and dandelion, a traditional diuretic. Both work by moving water and stool, which is not the same thing as changing fat tissue, so the scale reading returns once you rehydrate. Abdominal cramping is a commonly reported effect of stimulant laxatives, and prolonged use is not something to undertake without medical advice. The wider category evidence is no better: the 2021 systematic review in Obesity covering 315 randomised controlled trials found little high-quality support for supplement-driven weight loss. Our desk found no human trial testing these blends against the body-composition changes measured in the SWAN cohort. Put the money toward protein.
What we like
- None that address the measured mechanism
Tradeoffs
- Laxative and diuretic action moves water and stool, not fat tissue
- Cramping is a commonly reported effect of stimulant laxatives such as senna
- No human trial has tested these blends against perimenopausal body-composition change
How we picked these
We compared the supplements women in their 40s are actively buying for perimenopause weight change against the human-trial research. Three filters: (1) at least one peer-reviewed adult-population study at the dose the product uses, (2) standardized extracts and disclosed actives (not proprietary blends), and (3) a sustainable daily ritual format — because the literature uses 4-to-12-week windows and a supplement you cannot stick with for two months is useless.
We do not personally test products. We earn affiliate commissions on some of the links above; the picks are based on the literature, not on commission size. Our full disclosure page covers how we choose what to recommend.
Side-by-side comparison
| Supplement | Best for | Our rating | Price | |
|---|---|---|---|---|
| Berberine | Best Overall for the Glucose Driver | ★★★★★ 4.4/5 | From $20 | Check price → |
| Magnesium glycinate | Best Supporting Player | ★★★★★ 4.2/5 | From $18 | Check price → |
| Stimulant fat-burners | What We Would Skip | ★★★★★ 1.7/5 | $20–$60 | Not recommended |
| “Menopause belly” detox teas | What We Would Skip | ★★★★★ 1.5/5 | $15–$40 | Not recommended |
Not sure which one is for you?
Take the 2-minute perimenopause type quiz
Map your top 3 symptoms to the supplement category most likely to help. Free, no email required to start.
Start the quiz →